The average of price targets set by Wall Street analysts indicates a potential upside of 28.6% in Corcept (CORT). While the effectiveness of this highly sought-after metric is questionable, the ...

The Nintendo Switch 2 will feature exclusive new versions of The Legend of Zelda: Breath of the Wild and Tears of the Kingdom ...

Perspective Therapeutics (CATX) has been on a downward spiral lately with significant selling pressure. After declining 16.6% ...

Edgewise Therapeutics (EWTX) fell 10.6% in premarket trade after it priced its offering to raise $200 million.

DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) announced a key milestone in its ACESOT-1051 clinical trial, as the ...

Icelandic drug discovery and development company Arctic Therapeutics (ATx) today announced the publication of research in JAMA Neurology, which informs a possible therapeutic strategy to treat a rare ...

Contracts between Southwestern Health Resources – which includes Texas Health Resources and UT Southwestern – and Blue Cross ...

The state's largest insurer couldn't come to a deal with the region's top hospital and one of its leading networks.

Corcept's relacorilant hits phase 3 trial success in ovarian cancer, lifting shares 90%. Click here to find out why I rate ...

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money ...

NEW: Thousands of people have lost in-network insurance coverage after the April 1 deadline passed for negotiations. In the ...

SNUG01 is a first-in-class targeted gene therapy that’s designed to increase the levels of TRIM72, a protein with ...